Evidence map›Paper›PMID 26484708›Full record

ArticleGastroenterology2016

Hepatic Arterial Infusion of Low-Density Lipoprotein Docosahexaenoic Acid Nanoparticles Selectively Disrupts Redox Balance in Hepatoma Cells and Reduces Growth of Orthotopic Liver Tumors in Rats.

Xiaodong Wen, Lacy Reynolds, Rohit S Mulik, Soo Young Kim, Tim Van Treuren, Liem H Nguyen, Hao Zhu, Ian R Corbin

Open access · bronzeAbstract read
In one paragraph

Article in Gastroenterology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 60 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Marine biomaterials in biomedical nano/micro-systems.Journal of nanobiotechnology · 2023
    Review
  7. Review
  8. Recent Development of LDL-Based Nanoparticles for Cancer Therapy.Pharmaceuticals (Basel, Switzerland) · 2022
    Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Circulating Fatty Acids Associated with Advanced Liver Fibrosis and Hepatocellular Carcinoma in South Texas Hispanics.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2021
    Article
  15. Observational
  16. Functional Doxorubicin-Loaded Omega-3 Unsaturated Fatty Acids Nanoparticles in Reversing Hepatocellular Carcinoma Multidrug Resistance.Medical science monitor : international medical journal of experimental and clinical research · 2021
    Article
  17. Assessing the safety of transarterial locoregional delivery of low-density lipoprotein docosahexaenoic acid nanoparticles to the rat liver.European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V · 2021
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Xiaodong WenAdvanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, Texas.
Lacy ReynoldsAdvanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, Texas.
Rohit S MulikAdvanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, Texas.
Soo Young KimAdvanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, Texas.
Tim Van TreurenAdvanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, Texas.
Liem H NguyenChildren's Research Institute, Department of Pediatrics and Internal Medicine, Simmons Comprehensive Cancer Center, Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, Texas; Internal Medicine Division of Liver and Digestive Diseases, University of Texas Southwestern Medical Center, Dallas, Texas.
Hao ZhuChildren's Research Institute, Department of Pediatrics and Internal Medicine, Simmons Comprehensive Cancer Center, Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, Texas; Internal Medicine Division of Liver and Digestive Diseases, University of Texas Southwestern Medical Center, Dallas, Texas.
Ian R CorbinAdvanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, Texas; Internal Medicine Division of Liver and Digestive Diseases, University of Texas Southwestern Medical Center, Dallas, Texas. Electronic address: ian.corbin@utsouthwestern.edu.
Southwestern Medical Center · USThe University of Texas Southwestern Medical Center · US

Funding

UT Southwestern Medical Center Simmons Comprehensive Cancer CenterP30CA142543 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI Sandi Leigh Pruitt · 2010 to 2026
$53.7M
UT Southwestern Center for Translational Medicine (UL1/KL2/TL1)UL1TR001105 · NCATS · UT SOUTHWESTERN MEDICAL CENTER · PI TOTO, ROBERT DANIEL · 2013 to 2017
$24.5M
UT Southwestern Small Animal Imaging ResourceU24CA126608 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI MASON, RALPH P., SHERRY, DEAN · 2007 to 2011
$2.3M
Reactivation of embryonic growth programs in liver cancerR01CA190525 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI ZHU, HAO · 2015 to 2019
$1.8M
Metabolic roles for Lin28-let-7 miRNA pathway in sarcoma tumorigenesisK08CA157727 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI ZHU, HAO · 2011 to 2015
$807k
Howard Hughes Medical InstituteNCATS NIH HHS UL1 TR001105NCI NIH HHS 1R01CA190525NCI NIH HHS 5K08CA157727NCI NIH HHS 5P30 CA 142543-05NCI NIH HHS K08 CA157727NCI NIH HHS P30 CA142543NCI NIH HHS R01 CA190525NCI NIH HHS U24 CA126608
6 · The paper itself

Abstract

BACKGROUND &

aimsDietary intake of the natural omega-3 fatty acid docosahexaenoic acid (DHA) has been implicated in protecting patients with viral hepatitis B or C from developing hepatocellular carcinoma (HCC). Little is known about the effects of DHA on established solid tumors. Here we describe a low-density lipoprotein-based nanoparticle that acts as a transporter for unesterified DHA (LDL-DHA) and demonstrates selective cytotoxicity toward HCC cells. We investigated the ability of LDL-DHA to reduce growth of orthotopic hepatomas in rats.

methodsAxC-Irish (ACI) rats were given intrahepatic injections of rat hepatoma cells (H4IIE); 24 tumor-bearing rats (mean tumor diameter, ∼1 cm) were subject to a single hepatic artery injection of LDL nanoparticles (2 mg/kg) loaded with DHA (LDL-DHA), triolein (LDL-TO), or sham surgery controls. Tumor growth was measured by magnetic resonance imaging and other methods; tumor, liver, and serum samples were collected and assessed by histochemical, immunofluorescence, biochemical, and immunoblot analyses.

resultsThree days after administration of LDL-TO or sham surgery, the control rats had large, highly vascularized tumors that contained proliferating cells. However, rats given LDL-DHA had smaller, pale tumors that were devoid of vascular supply and >80% of the tumor tissue was necrotic. Four to 6 days after injection of LDL-DHA, the tumors were 3-fold smaller than those of control rats. The liver tissue that surrounded the tumors showed no histologic or biochemical evidence of injury. Injection of LDL-DHA into the hepatic artery of rats selectively deregulated redox reactions in tumor tissues by increasing levels of reactive oxygen species and lipid peroxidation, depleting and oxidizing glutathione and nicotinamide adenine dinucleotide phosphate, and significantly down-regulating the antioxidant enzyme glutathione peroxidase-4. Remarkably, the redox balance in the surrounding liver was not disrupted.

conclusionLDL-DHA nanoparticle selectively kills hepatoma cells and reduces growth of orthotopic liver tumors in rats. It induces tumor-specific necrosis by selectively disrupting redox balance within the cancer cell.

Indexed as

Drug CarriersNanoparticlesAnimalsAntineoplastic AgentsAntioxidantsCarcinoma, HepatocellularCell Line, TumorCell ProliferationDocosahexaenoic AcidsDose-Response Relationship, DrugHepatic ArteryInfusions, Intra-ArterialLipid PeroxidationLipoproteins, LDLLiver NeoplasmsNecrosisAntineoplastic AgentsAntioxidantsDocosahexaenoic AcidsDrug CarriersLipoproteins, LDLReactive Oxygen SpeciesLipid PeroxidationLiver CancerNanomedicineOmega-3 Fatty Acids

Identifiers

PMID26484708
PMCPMC4727982
OpenAlexW2124526750

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.